MMCAP International Inc. SPC
Position in VRXA — Veraxa Biotech AG - Post de-SPAC
CIK 1304857
GRAND CAYMAN, E9
Position in VRXA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
125,000
first reported quarter
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MMCAP International Inc. SPC holds $3,535,908 across 11 Biotechnology names. VRXA ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PLRZ |
Polyrizon Ltd.
|
199,470 | $2,497,364 | |
| 2 | AKTX |
Akari Therapeutics Plc
|
100,000 | $1,024,500 | |
| 3 | OABI |
OmniAb, Inc.
|
158,333 | $14,044 | |
| 4 | OCS |
Oculis Holding AG
|
73,025 | $0 | |
| 5 | TVGN |
Tevogen Inc.
|
650,000 | $0 | |
| 6 | VRXA |
Veraxa Biotech AG - Post de-SPAC
This page
|
125,000 | $0 | |
| 7 | PBM |
Psyence Biomedical Ltd.
|
600,000 | $0 | |
| 8 | APLM |
Apollomics Inc.
|
250,000 | $0 |
No Holdings History
No holdings records found for this institution in VRXA.